List of insiders holdings for Kailera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Kaplan Andrew T. Director 10% Owner | 2026-04-20 18:00:25 | 38,300 26,255,581 | 26,293,881 | Form 4 |
| 2 | BAIN CAPITAL INVESTORS LLC Bain Capital XIV General Partner LLC Bain Capital Fund XIV L.P. BCPE Perseus Investor GP LLC BCPE Perseus Investor LP 10% Owner | 2026-04-23 19:34:49 | 26,255,581 0 | 26,255,581 | Form 13D |
| 3 | Koppel Adam Director 10% Owner | 2026-04-20 18:08:42 | 38,300 22,583,268 | 22,621,568 | Form 4 |
| 4 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. BCLS Fund IV Investments GP LLC BCLS Fund IV Investments L.P. 10% Owner | 2026-04-23 20:01:50 | 22,583,268 0 | 22,583,268 | Form 13D |
| 5 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. 10% Owner | 2026-08-05 06:04:45 | 11,511,853 0 | 11,511,853 | Form 13G |
| 6 | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2026-08-14 08:03:07 | 10,776,820 0 | 10,776,820 | Form 13G |
| 7 | CANADA PENSION PLAN INVESTMENT BOARD CPP Investment Board Private Holdings (4) Inc. 10% Owner | 2026-08-14 16:01:02 | 7,304,688 0 | 7,304,688 | Form 13G |
| 8 | Stuart Partners LLC 10% Owner | 2026-04-16 17:45:16 | 1,428,571 0 | 1,428,571 | Form 3 |
| 9 | Renaud Ronald C JR CEO & President | 2026-06-11 16:05:10 | 855,920 0 | 855,920 | Form 4 |
| 10 | Nicholson Nur Chief Technology Officer | 2026-09-09 19:29:45 | 220,000 0 | 220,000 | Form 4 |
| 11 | Burgess Paul D. See Remarks | 2026-04-20 17:14:12 | 200,000 0 | 200,000 | Form 4 |
| 12 | Wasserman Scott M. Chief Medical Officer | 2026-04-20 17:08:56 | 200,000 0 | 200,000 | Form 4 |
| 13 | Pagan Douglas W. Chief Financial Officer | 2026-04-20 17:01:51 | 200,000 0 | 200,000 | Form 4 |
| 14 | Tregoning Kathleen See Remarks | 2026-07-08 16:20:04 | 175,000 0 | 175,000 | Form 4 |
| 15 | Coleman Jamie Beth Chief Commercial Officer | 2026-04-20 17:13:05 | 150,000 0 | 150,000 | Form 4 |
| 16 | Akamine Scott Chief Legal Officer | 2026-04-20 17:19:15 | 120,000 0 | 120,000 | Form 4 |
| 17 | Cloghessy Paula Chief People Officer | 2026-04-20 17:19:23 | 120,000 0 | 120,000 | Form 4 |
| 18 | MILLIGAN JOHN F Director | 2026-04-20 17:13:40 | 38,300 0 | 38,300 | Form 4 |
| 19 | MACKAY MARTIN Director | 2026-04-20 17:10:09 | 38,300 0 | 38,300 | Form 4 |
| 20 | Hite Christopher Director | 2026-04-20 17:05:01 | 38,300 0 | 38,300 | Form 4 |
| 21 | Clyburn Frank Director | 2026-04-20 17:04:32 | 38,300 0 | 38,300 | Form 4 |
| 22 | Liu Yuting Director | 2026-04-16 19:40:40 | 0 0 | 0 | Form 3 |